CRMD Cormedix Inc

Cormedix Inc is a commercial-stage biopharmaceutical company. It focuses on development and commercializing prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases.

$3.18  -0.06 (-1.85%)
As of 05/26/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/13/2010
Outstanding shares:  39,123,259
Average volume:  339,708
Market cap:   $126,759,359
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJ0LT31
Valuation   (See tab for details)
PE ratio:   -4.44
PB ratio:   2.06
PS ratio:   0.00
Return on equity:   -46.81%
Net income %:   -25,407.46%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy